Deciphering how the GR forms oligomers—through the binding of several subunits—opens a crucial avenue for developing more ...
Using psychedelics to treat psychiatric diseases has become less controversial as scientists continue to reveal their ...
See related article at Key points In this issue’s research article, Rebić and colleagues show that rates of opioid prescribing across 6 Canadian provinces declined gradually from 2018 to 2022, with n ...
Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more than just food.
– Positive results from ALLEVIATE-1 Phase 3 pivotal trial for cebranopadol which demonstrates statistically significant pain reduction compared to placebo in patients after abdominoplasty will be ...
Mira Pharmaceuticals MIRA stock jumped 70% after-hours on preclinical data showing Mira-55 outperformed morphine in pain relief and inflammation reduction.
Stocktwits on MSN
Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making
Shares of Mira Pharmaceuticals surged 70% after-hours on Wednesday after the company announced new preclinical data showing ...
THURSDAY, Oct. 9, 2025 (HealthDay News) — A widely prescribed opioid painkiller is not all it’s cracked up to be, a new evidence review has concluded. The opioid painkiller tramadol does little to ...
This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.
A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback